Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

4.020 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Dayforce, Applied Digital, GoodRx, First Solar, TeraWulf: Stocks Making The Biggest Moves Today
Dayforce shares skyrocketed 26% in Monday’s midday trade after reports suggested that private equity firm Thoma Bravo is in talks to acquire the human resources firm. 
Via Stocktwits
Topics Artificial Intelligence ETFs Economy
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Soho House, GoodRx Holdings, Dayforce And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
Earnings Scheduled For August 6, 2025
 
Via Benzinga
Monday's session: top gainers and losers
Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Ozempic And Wegovy Now Available Through GoodRx At Reduced Self-Pay Price, Stock Skyrockets
GoodRx and Novo Nordisk launch a $499 monthly self-pay option for Ozempic and Wegovy, expanding access at 70,000 pharmacies across the U.S. 
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill
Novo Nordisk Stock Surges After Pharma Major Cuts Ozempic Cost to $499 Per Month For Self-Paying Patients
The new offer aims to assist Type 2 diabetes patients who are uninsured or choose to self-pay, and may potentially face prices at or above wholesale cost. 
Via Stocktwits
GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month
From GoodRx
Via Business Wire
3 Small-Cap Stocks Walking a Fine Line
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
3 Stocks Under $10 We Approach with Caution
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as... 
Via StockStory
Topics Retirement
GDRX Q2 Deep Dive: Headwinds from Rite Aid and PBM Disruptions Offset Pharma Solutions Growth
Healthcare tech company GoodRx (NASDAQ:GDRX) missed Wall Street’s revenue expectations in Q2 CY2025 as sales only rose 1.2% year on year to $203.1 million. Its non-GAAP profit of $0.09 per share was in... 
Via StockStory
Topics Bankruptcy
GoodRx (NASDAQ:GDRX) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops
Healthcare tech company GoodRx (NASDAQ:GDRX) missed Wall Street’s revenue expectations in Q2 CY2025 as sales only rose 1.2% year on year to $203.1 million. Its non-GAAP profit of $0.09 per share was in... 
Via StockStory
GoodRx Reports Second Quarter 2025 Results
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx (GDRX) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare tech company GoodRx (NASDAQ:GDRX) will be reporting earnings this Wednesday after the bell. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
GoodRx Appoints Amazon Pharmacy Veteran Laura Jensen as President of Pharma Solutions
From GoodRx
Via Business Wire
GOODRX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of GoodRx Holdings, Inc. - GDRX
From Kahn Swick & Foti, LLC
Via Business Wire
Curious about the stocks that are showing activity after the closing bell on Friday?
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
1 Healthcare Stock for Long-Term Investors and 2 to Be Wary Of
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
GoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference Call
From GoodRx Holdings, Inc.
Via Business Wire
3 Low-Volatility Stocks Skating on Thin Ice
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
SolarEdge, GoodRx, BigCommerce, 8x8, and Angi Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +1.4%, S&P 500 +1.0%) on hopes the reported ceasefire between Israel and Iran will hold. This de-escalation... 
Via StockStory
Topics Economy Stocks
3 Cash-Producing Stocks in the Doghouse
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
GDRX Q1 Earnings Call: Management Focuses on Pharmacy Partnerships and Marketplace Evolution
Healthcare tech company GoodRx (NASDAQ:GDRX) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 2.6% year on year to $203 million. The company’s outlook for the full year was close to... 
Via StockStory
Topics Bankruptcy
3 Small-Cap Stocks Facing Headwinds
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers
From GoodRx
Via Business Wire
GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing
From GoodRx
Via Business Wire
3 Stocks Under $10 with Mounting Challenges
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as... 
Via StockStory
GoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer Productivity
From GoodRx
Via Business Wire
Healthcare Technology Stocks Q1 Recap: Benchmarking GoodRx (NASDAQ:GDRX)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at healthcare technology stocks, starting... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.